LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 22 of 497
Next
>>
>
526 to 550 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	JW-7-24-1	0.12	uM	LJP6	1	B23	72	hr	1097	3175	3769	0.8423	0.7775
BT-20	JW-7-24-1	0.12	uM	LJP6	2	B23	72	hr	1097	3076	3769	0.8160	0.7405
BT-20	JW-7-24-1	0.12	uM	LJP6	3	B23	72	hr	1097	2926	3769	0.7762	0.6843
BT-20	Lapatinib	0.12	uM	LJP6	1	M23	72	hr	1097	3364	3769	0.8924	0.8482
BT-20	Lapatinib	0.12	uM	LJP6	2	M23	72	hr	1097	3286	3769	0.8717	0.8191
BT-20	Lapatinib	0.12	uM	LJP6	3	M23	72	hr	1097	3192	3769	0.8468	0.7839
BT-20	LDN-193189	0.12	uM	LJP5	1	G05	72	hr	1097	3140	3769	0.8330	0.7644
BT-20	LDN-193189	0.12	uM	LJP5	2	G05	72	hr	1097	3632	3769	0.9635	0.9485
BT-20	LDN-193189	0.12	uM	LJP5	3	G05	72	hr	1097	3393	3769	0.9001	0.8591
BT-20	Linifanib	0.12	uM	LJP6	1	J11	72	hr	1097	3801	3769	1.0083	1.0118
BT-20	Linifanib	0.12	uM	LJP6	2	J11	72	hr	1097	3550	3769	0.9418	0.9179
BT-20	Linifanib	0.12	uM	LJP6	3	J11	72	hr	1097	3938	3769	1.0447	1.0630
BT-20	Linsitinib	0.12	uM	LJP5	1	O23	72	hr	1097	3456	3769	0.9168	0.8827
BT-20	Linsitinib	0.12	uM	LJP5	2	O23	72	hr	1097	3866	3769	1.0256	1.0361
BT-20	Linsitinib	0.12	uM	LJP5	3	O23	72	hr	1097	3526	3769	0.9354	0.9089
BT-20	Mitoxantrone	0.12	uM	LJP5	1	C23	72	hr	1097	1026	3769	0.2722	-0.0267
BT-20	Mitoxantrone	0.12	uM	LJP5	2	C23	72	hr	1097	1102	3769	0.2923	0.0018
BT-20	Mitoxantrone	0.12	uM	LJP5	3	C23	72	hr	1097	1280	3769	0.3396	0.0684
BT-20	Mitoxantrone	0.12	uM	LJP6	1	C23	72	hr	1097	1172	3769	0.3109	0.0280
BT-20	Mitoxantrone	0.12	uM	LJP6	2	C23	72	hr	1097	1146	3769	0.3040	0.0182
BT-20	Mitoxantrone	0.12	uM	LJP6	3	C23	72	hr	1097	1131	3769	0.3000	0.0126
BT-20	MK2206	0.12	uM	LJP6	1	F05	72	hr	1097	3049	3769	0.8089	0.7304
BT-20	MK2206	0.12	uM	LJP6	2	F05	72	hr	1097	2950	3769	0.7826	0.6933
BT-20	MK2206	0.12	uM	LJP6	3	F05	72	hr	1097	2961	3769	0.7855	0.6974
BT-20	Neratinib	0.12	uM	LJP5	1	A17	72	hr	1097	2410	3769	0.6393	0.4912

|<
<<
Previous
Page 22 of 497
Next
>>
>
526 to 550 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)